Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Clear cell renal cell carcinoma). Showing records 1 – 30 of 39561 total matches.

[1] [2] [3] [4] [5] … [1319]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


University of the Western Cape

1. Calvert-Joshua, Tracey. Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants .

Degree: 2015, University of the Western Cape

 Kidney cancers, of which clear cell renal cell carcinoma comprises an estimated 70%, have been placed amongst the top ten most common cancers in both… (more)

Subjects/Keywords: Non-coding DNA; Gene dysregulation; Aberrant methylation; Renal cell carcinoma; Clear cell renal cell carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calvert-Joshua, T. (2015). Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/5022

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Calvert-Joshua, Tracey. “Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants .” 2015. Thesis, University of the Western Cape. Accessed April 14, 2021. http://hdl.handle.net/11394/5022.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Calvert-Joshua, Tracey. “Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants .” 2015. Web. 14 Apr 2021.

Vancouver:

Calvert-Joshua T. Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants . [Internet] [Thesis]. University of the Western Cape; 2015. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/11394/5022.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Calvert-Joshua T. Integrating regulatory and methylome data for the discovery of clear cell Renal Cell Carcinoma (ccRCC) variants . [Thesis]. University of the Western Cape; 2015. Available from: http://hdl.handle.net/11394/5022

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Syafruddin, Saiful Effendi. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma.

Degree: PhD, 2019, University of Cambridge

Clear cell renal cell carcinoma (ccRCC) is characterised by frequent inactivation of the VHL tumour suppressor gene and consequent accumulation of HIF2A that drives tumourigenesis.… (more)

Subjects/Keywords: Clear Cell Renal Cell Carcinoma; Super Enhancer; Cancer Biology; Transcriptional regulation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Syafruddin, S. E. (2019). A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/294470

Chicago Manual of Style (16th Edition):

Syafruddin, Saiful Effendi. “A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://www.repository.cam.ac.uk/handle/1810/294470.

MLA Handbook (7th Edition):

Syafruddin, Saiful Effendi. “A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma.” 2019. Web. 14 Apr 2021.

Vancouver:

Syafruddin SE. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 14]. Available from: https://www.repository.cam.ac.uk/handle/1810/294470.

Council of Science Editors:

Syafruddin SE. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in clear cell renal cell carcinoma. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/294470


Queen Mary, University of London

3. Smith, K. J. Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma.

Degree: PhD, 2018, Queen Mary, University of London

 Sequential use of targeted therapies has significantly improved overall survival in metastatic clear cell renal cell carcinoma (ccRCC) but durable responses remain rare. Improved prognostic… (more)

Subjects/Keywords: LIM-domain loss; Barts Cancer Institute; clear cell renal cell carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, K. J. (2018). Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/56084 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775309

Chicago Manual of Style (16th Edition):

Smith, K J. “Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma.” 2018. Doctoral Dissertation, Queen Mary, University of London. Accessed April 14, 2021. http://qmro.qmul.ac.uk/xmlui/handle/123456789/56084 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775309.

MLA Handbook (7th Edition):

Smith, K J. “Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma.” 2018. Web. 14 Apr 2021.

Vancouver:

Smith KJ. Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2018. [cited 2021 Apr 14]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/56084 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775309.

Council of Science Editors:

Smith KJ. Identifying and targeting LIM-domain loss in clear cell renal cell carcinoma. [Doctoral Dissertation]. Queen Mary, University of London; 2018. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/56084 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775309


University of Southern California

4. Shen, Hui. Integrative genomic and epigenomic analysis of human cancer.

Degree: PhD, Genetic, Molecular and Cellular Biology, 2013, University of Southern California

 Cancer arises as a consequence of cumulative disruptions to cellular growth control, with Darwinian selection for those heritable changes which provide the greatest clonal advantage.… (more)

Subjects/Keywords: cancer; epigenome; clear cell renal cell carcinoma; ovarian cancer; HNF1B

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shen, H. (2013). Integrative genomic and epigenomic analysis of human cancer. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/254284/rec/3555

Chicago Manual of Style (16th Edition):

Shen, Hui. “Integrative genomic and epigenomic analysis of human cancer.” 2013. Doctoral Dissertation, University of Southern California. Accessed April 14, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/254284/rec/3555.

MLA Handbook (7th Edition):

Shen, Hui. “Integrative genomic and epigenomic analysis of human cancer.” 2013. Web. 14 Apr 2021.

Vancouver:

Shen H. Integrative genomic and epigenomic analysis of human cancer. [Internet] [Doctoral dissertation]. University of Southern California; 2013. [cited 2021 Apr 14]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/254284/rec/3555.

Council of Science Editors:

Shen H. Integrative genomic and epigenomic analysis of human cancer. [Doctoral Dissertation]. University of Southern California; 2013. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/254284/rec/3555

5. 甲斐, 友喜. Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway.

Degree: 博士(医学), 2017, Oita University / 大分大学

 We have previously reported that Salvador homologue 1 (SAV1), a component of the Hippo pathway, is significantly down-regulated in high-grade clear cell renal cell carcinoma(more)

Subjects/Keywords: SAV1; Hippo pathway; YAP1; clear cell renal cell carcinoma; knockout mouse; atypical renal tubule

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

甲斐, . (2017). Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. (Thesis). Oita University / 大分大学. Retrieved from http://hdl.handle.net/10559/15764

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

甲斐, 友喜. “Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway.” 2017. Thesis, Oita University / 大分大学. Accessed April 14, 2021. http://hdl.handle.net/10559/15764.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

甲斐, 友喜. “Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway.” 2017. Web. 14 Apr 2021.

Vancouver:

甲斐 . Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. [Internet] [Thesis]. Oita University / 大分大学; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10559/15764.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

甲斐 . Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. [Thesis]. Oita University / 大分大学; 2017. Available from: http://hdl.handle.net/10559/15764

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

6. Rahmy, S. The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma.

Degree: 2014, Universiteit Utrecht

 Abstract Up to 88% of patients who suffer from clear cell renal carcinoma (ccRCC) have inactivating mutations in the Von Hippel-Lindau tumor suppressor gene. Also… (more)

Subjects/Keywords: Von Hippel-Lindau; clear cell renal carcinoma; zebrafish

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rahmy, S. (2014). The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/302210

Chicago Manual of Style (16th Edition):

Rahmy, S. “The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma.” 2014. Masters Thesis, Universiteit Utrecht. Accessed April 14, 2021. http://dspace.library.uu.nl:8080/handle/1874/302210.

MLA Handbook (7th Edition):

Rahmy, S. “The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma.” 2014. Web. 14 Apr 2021.

Vancouver:

Rahmy S. The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma. [Internet] [Masters thesis]. Universiteit Utrecht; 2014. [cited 2021 Apr 14]. Available from: http://dspace.library.uu.nl:8080/handle/1874/302210.

Council of Science Editors:

Rahmy S. The role of the Von Hippel-Lindau tumor suppressor protein in clear cell renal carcinoma. [Masters Thesis]. Universiteit Utrecht; 2014. Available from: http://dspace.library.uu.nl:8080/handle/1874/302210

7. 髙橋, 美香. Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.

Degree: 博士(医学), 2017, Oita University / 大分大学

 Previously, we reported that genomic loss of 14q occurs more frequently in high-grade than in low-grade clear cell renal cell carcinomas (ccRCCs), and has a… (more)

Subjects/Keywords: 14q loss; Apoptosis; clear cell renal cell carcinoma; The Cancer Genome Atlas; WDR20

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

髙橋, . (2017). Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma. (Thesis). Oita University / 大分大学. Retrieved from http://hdl.handle.net/10559/15761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

髙橋, 美香. “Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.” 2017. Thesis, Oita University / 大分大学. Accessed April 14, 2021. http://hdl.handle.net/10559/15761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

髙橋, 美香. “Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.” 2017. Web. 14 Apr 2021.

Vancouver:

髙橋 . Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma. [Internet] [Thesis]. Oita University / 大分大学; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10559/15761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

髙橋 . Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma. [Thesis]. Oita University / 大分大学; 2017. Available from: http://hdl.handle.net/10559/15761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

8. Ilić, Bojana B. 1977-. Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega.

Degree: Biološki fakultet, 2018, Univerzitet u Beogradu

Biologija - molekularna biologija /Biology - Molecular biology

Sporadični svetloćelijski karcinomi bubrega asocirani su sa mutacijama tumor supresorskog gena VHL kod 60-80 % pacijenata. U… (more)

Subjects/Keywords: clear cell renal cell carcinoma; VHL gene; mTOR signaling pathway; cellular metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ilić, B. B. 1. (2018). Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:17628/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ilić, Bojana B 1977-. “Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega.” 2018. Thesis, Univerzitet u Beogradu. Accessed April 14, 2021. https://fedorabg.bg.ac.rs/fedora/get/o:17628/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ilić, Bojana B 1977-. “Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega.” 2018. Web. 14 Apr 2021.

Vancouver:

Ilić BB1. Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega. [Internet] [Thesis]. Univerzitet u Beogradu; 2018. [cited 2021 Apr 14]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:17628/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ilić BB1. Efekat mutacije gena VHL na nivo ekspresije proteina mTOR signalnog puta u svetloćelijskom karcinomu bubrega. [Thesis]. Univerzitet u Beogradu; 2018. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:17628/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

9. Qiu, Bo. Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma.

Degree: 2015, University of Pennsylvania

 Two hallmarks of clear cell renal cell carcinoma (ccRCC) are constitutive hypoxia inducible factor (HIF) signaling and abundant intracellular lipid droplets (LDs). However, regulation of… (more)

Subjects/Keywords: Cancer; clear cell renal cell carcinoma; Endoplasmic reticulum; Lipid droplet; Lipid storage; Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Qiu, B. (2015). Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1960

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Qiu, Bo. “Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma.” 2015. Thesis, University of Pennsylvania. Accessed April 14, 2021. https://repository.upenn.edu/edissertations/1960.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Qiu, Bo. “Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma.” 2015. Web. 14 Apr 2021.

Vancouver:

Qiu B. Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma. [Internet] [Thesis]. University of Pennsylvania; 2015. [cited 2021 Apr 14]. Available from: https://repository.upenn.edu/edissertations/1960.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Qiu B. Tumor Promoting Functions of Lipid Storage in Clear Cell Renal Cell Carcinoma. [Thesis]. University of Pennsylvania; 2015. Available from: https://repository.upenn.edu/edissertations/1960

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Marcela Sampaio Lima. Expressão de Ciclina D1 em Carcinoma de Células Renais.

Degree: 2013, University of São Paulo

Carcinoma de Células Renais (CCR) representa uma família de tumores distintos com evolução clínica imprevisível. Uma variedade de moléculas tem sido avaliada como marcadores prognósticos… (more)

Subjects/Keywords: Carcinoma de células renais; carcinoma renal de células claras; ciclina D1; fatores prognósticos; clear cell renal cell carcinoma; cyclin D1; prognostic factors; Renal cell carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lima, M. S. (2013). Expressão de Ciclina D1 em Carcinoma de Células Renais. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/17/17143/tde-21102013-215129/

Chicago Manual of Style (16th Edition):

Lima, Marcela Sampaio. “Expressão de Ciclina D1 em Carcinoma de Células Renais.” 2013. Masters Thesis, University of São Paulo. Accessed April 14, 2021. http://www.teses.usp.br/teses/disponiveis/17/17143/tde-21102013-215129/.

MLA Handbook (7th Edition):

Lima, Marcela Sampaio. “Expressão de Ciclina D1 em Carcinoma de Células Renais.” 2013. Web. 14 Apr 2021.

Vancouver:

Lima MS. Expressão de Ciclina D1 em Carcinoma de Células Renais. [Internet] [Masters thesis]. University of São Paulo; 2013. [cited 2021 Apr 14]. Available from: http://www.teses.usp.br/teses/disponiveis/17/17143/tde-21102013-215129/.

Council of Science Editors:

Lima MS. Expressão de Ciclina D1 em Carcinoma de Células Renais. [Masters Thesis]. University of São Paulo; 2013. Available from: http://www.teses.usp.br/teses/disponiveis/17/17143/tde-21102013-215129/

11. Conceição, André Luis Giacometti [UNESP]. Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras.

Degree: 2016, Universidade Estadual Paulista (UNESP)

Submitted by ANDRÉ LUIS GIACOMETTI CONCEIÇÃO null ([email protected]) on 2016-03-08T12:40:30Z No. of bitstreams: 1 Arquivo_Completo_-_Tese_Doutorado_-_André_Luis_Giacometti_Conceição.pdf: 1296182 bytes, checksum: 29c1b4fbebefc1b96e79210f433f4d2f (MD5)

Approved for entry into archive… (more)

Subjects/Keywords: Carcinoma renal de células claras; Expressão gênica; Epigenética; Clear cell renal cell carcinoma; Gene expression; Epigenetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Conceição, A. L. G. [. (2016). Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras. (Doctoral Dissertation). Universidade Estadual Paulista (UNESP). Retrieved from http://hdl.handle.net/11449/136188

Chicago Manual of Style (16th Edition):

Conceição, André Luis Giacometti [UNESP]. “Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras.” 2016. Doctoral Dissertation, Universidade Estadual Paulista (UNESP). Accessed April 14, 2021. http://hdl.handle.net/11449/136188.

MLA Handbook (7th Edition):

Conceição, André Luis Giacometti [UNESP]. “Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras.” 2016. Web. 14 Apr 2021.

Vancouver:

Conceição ALG[. Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras. [Internet] [Doctoral dissertation]. Universidade Estadual Paulista (UNESP); 2016. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/11449/136188.

Council of Science Editors:

Conceição ALG[. Análise da expressão e de mecanismos de regulação de genes envolvidos na transição epitélio mesênquima em carcinoma renal de células claras. [Doctoral Dissertation]. Universidade Estadual Paulista (UNESP); 2016. Available from: http://hdl.handle.net/11449/136188

12. Richardson, Emma Kay. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.

Degree: PhD, 2019, University of Cambridge

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. ccRCCs exhibit considerable genetic intratumour heterogeneity, and current therapies lack long-term… (more)

Subjects/Keywords: ccRCC; HNF1B; MYC; lineage; transcription; factor; transcription factor; hepatocyte nuclear factor; RCC; clear cell renal cell carcinoma; renal cell carcinoma; lineage transcription factor; kidney; renal

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Richardson, E. K. (2019). Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/290609

Chicago Manual of Style (16th Edition):

Richardson, Emma Kay. “Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://www.repository.cam.ac.uk/handle/1810/290609.

MLA Handbook (7th Edition):

Richardson, Emma Kay. “Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.” 2019. Web. 14 Apr 2021.

Vancouver:

Richardson EK. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 14]. Available from: https://www.repository.cam.ac.uk/handle/1810/290609.

Council of Science Editors:

Richardson EK. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/290609


University of Cambridge

13. Richardson, Emma Kay. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.

Degree: PhD, 2019, University of Cambridge

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. ccRCCs exhibit considerable genetic intratumour heterogeneity, and current therapies lack long-term… (more)

Subjects/Keywords: ccRCC; HNF1B; MYC; lineage; transcription; factor; transcription factor; hepatocyte nuclear factor; RCC; clear cell renal cell carcinoma; renal cell carcinoma; lineage transcription factor; kidney; renal

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Richardson, E. K. (2019). Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.37831 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774617

Chicago Manual of Style (16th Edition):

Richardson, Emma Kay. “Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 14, 2021. https://doi.org/10.17863/CAM.37831 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774617.

MLA Handbook (7th Edition):

Richardson, Emma Kay. “Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma.” 2019. Web. 14 Apr 2021.

Vancouver:

Richardson EK. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 14]. Available from: https://doi.org/10.17863/CAM.37831 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774617.

Council of Science Editors:

Richardson EK. Identification and characterisation of HNF1B as a pro-tumorigenic lineage factor in clear cell renal cell carcinoma. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.37831 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.774617


University of Queensland

14. Kamli, Hossam. Exploring resistance of renal cell carcinoma to sunitinib therapy.

Degree: Faculty of Medicine, 2020, University of Queensland

Renal cell carcinomas (RCC) are highly metastatic and therapy-resistant. Several novel tyrosine kinase inhibitors (TKI) targeting angiogenesis have been introduced into clinical practice for RCC, the most… (more)

Subjects/Keywords: Angiogenesis; Apoptosis; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunotherapy; Inhibitors; Interleukin-6; Kidney cancer; Sunitinib-resistance; Tocilizumab; 0601 Biochemistry and Cell Biology; 1103 Clinical Sciences; 1107 Immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kamli, H. (2020). Exploring resistance of renal cell carcinoma to sunitinib therapy. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:3

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kamli, Hossam. “Exploring resistance of renal cell carcinoma to sunitinib therapy.” 2020. Thesis, University of Queensland. Accessed April 14, 2021. http://espace.library.uq.edu.au/view/UQ:3.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kamli, Hossam. “Exploring resistance of renal cell carcinoma to sunitinib therapy.” 2020. Web. 14 Apr 2021.

Vancouver:

Kamli H. Exploring resistance of renal cell carcinoma to sunitinib therapy. [Internet] [Thesis]. University of Queensland; 2020. [cited 2021 Apr 14]. Available from: http://espace.library.uq.edu.au/view/UQ:3.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kamli H. Exploring resistance of renal cell carcinoma to sunitinib therapy. [Thesis]. University of Queensland; 2020. Available from: http://espace.library.uq.edu.au/view/UQ:3

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Uniwersytet im. Adama Mickiewicza w Poznaniu

15. Majer-Burman, Weronika. Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) .

Degree: 2020, Uniwersytet im. Adama Mickiewicza w Poznaniu

 Rak nerki (RCC) należy do jednego z 10 najczęściej występujących nowotworów na świecie, RCC dzieli się na histologiczne podtypy: jasnokomówkowy ,brodawkowy, chromofobowy oraz onkocytomę. W… (more)

Subjects/Keywords: nowotwór nerki; jasnokomórkowy rak nerki; jasnokomórkowy rak nerki; biomarker nowotworowy; wolnokrążące DNA; miRNA; renal cell carcinoma; clear cell renal cell carcinoma; cancer biomarker; cell free DNA; miRNA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Majer-Burman, W. (2020). Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) . (Doctoral Dissertation). Uniwersytet im. Adama Mickiewicza w Poznaniu. Retrieved from http://hdl.handle.net/10593/25846

Chicago Manual of Style (16th Edition):

Majer-Burman, Weronika. “Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) .” 2020. Doctoral Dissertation, Uniwersytet im. Adama Mickiewicza w Poznaniu. Accessed April 14, 2021. http://hdl.handle.net/10593/25846.

MLA Handbook (7th Edition):

Majer-Burman, Weronika. “Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) .” 2020. Web. 14 Apr 2021.

Vancouver:

Majer-Burman W. Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) . [Internet] [Doctoral dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10593/25846.

Council of Science Editors:

Majer-Burman W. Nowe molekularne narzędzie umożliwiające monitoring choroby dla jasnokomórkowego raka nerki (ccRCC) . [Doctoral Dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2020. Available from: http://hdl.handle.net/10593/25846


University of Toronto

16. Zhang, Xiaoyu. Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma.

Degree: 2018, University of Toronto

Metastatic clear cell renal cell carcinoma (ccRCC) remains incurable with low 5-year survival rates despite various targeted therapies and checkpoint immunotherapy. Owing to the tumours’… (more)

Subjects/Keywords: Bi-specific T cell engaging antibody; Carbonic anhydrase IX; clear cell renal cell carcinoma; Immunotherapy; 0541

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, X. (2018). Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/89564

Chicago Manual of Style (16th Edition):

Zhang, Xiaoyu. “Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma.” 2018. Masters Thesis, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/89564.

MLA Handbook (7th Edition):

Zhang, Xiaoyu. “Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma.” 2018. Web. 14 Apr 2021.

Vancouver:

Zhang X. Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma. [Internet] [Masters thesis]. University of Toronto; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/89564.

Council of Science Editors:

Zhang X. Development and Characterization of Novel Therapeutic Biologics to Enhance Immune Targeting of Clear Cell Renal Cell Carcinoma. [Masters Thesis]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/89564

17. Fabbri, Lucilla. Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression.

Degree: Docteur es, Sciences de la vie et de la santé, 2019, Université Côte d'Azur (ComUE)

 Le voltage-dependent anion channel 1 (VDAC1) est une porine exprimée au niveau de la membrane externe des mitochondries et qui joue un rôle très important… (more)

Subjects/Keywords: Agressivité; Carcinome rénal à cellules claires; Cil primaire; Hypoxie; Métabolisme; VDAC1; Aggressiveness; Clear cell Renal Cell Carcinoma; Hypoxia; Primary cilium; VDAC1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fabbri, L. (2019). Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression. (Doctoral Dissertation). Université Côte d'Azur (ComUE). Retrieved from http://www.theses.fr/2019AZUR6033

Chicago Manual of Style (16th Edition):

Fabbri, Lucilla. “Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression.” 2019. Doctoral Dissertation, Université Côte d'Azur (ComUE). Accessed April 14, 2021. http://www.theses.fr/2019AZUR6033.

MLA Handbook (7th Edition):

Fabbri, Lucilla. “Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression.” 2019. Web. 14 Apr 2021.

Vancouver:

Fabbri L. Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression. [Internet] [Doctoral dissertation]. Université Côte d'Azur (ComUE); 2019. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2019AZUR6033.

Council of Science Editors:

Fabbri L. Rôle de la forme hypoxique VDAC1, VDAC1-∆C, dans l’expression du cil primaire et la progression tumorale : Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression. [Doctoral Dissertation]. Université Côte d'Azur (ComUE); 2019. Available from: http://www.theses.fr/2019AZUR6033


Uniwersytet im. Adama Mickiewicza w Poznaniu

18. Wrzesiński, Tomasz. Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe .

Degree: 2016, Uniwersytet im. Adama Mickiewicza w Poznaniu

 Rak nerki odpowiada za 2-3% wszystkich wykrywanych nowotworów w ciągu roku. Jego najczęściej występującą postacią jest rak nerkowokomórkowy, odpowiedzialny za 80% wszystkich przypadków. Wśród podtypów… (more)

Subjects/Keywords: rak jasnokomórkowy nerki; clear cell renal cell carcinoma; gen VHL; VHL gene; RNA-Seq; RNA-Seq; białka transbłonowe; transmembrane proteins

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wrzesiński, T. (2016). Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe . (Doctoral Dissertation). Uniwersytet im. Adama Mickiewicza w Poznaniu. Retrieved from http://hdl.handle.net/10593/14268

Chicago Manual of Style (16th Edition):

Wrzesiński, Tomasz. “Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe .” 2016. Doctoral Dissertation, Uniwersytet im. Adama Mickiewicza w Poznaniu. Accessed April 14, 2021. http://hdl.handle.net/10593/14268.

MLA Handbook (7th Edition):

Wrzesiński, Tomasz. “Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe .” 2016. Web. 14 Apr 2021.

Vancouver:

Wrzesiński T. Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe . [Internet] [Doctoral dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2016. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10593/14268.

Council of Science Editors:

Wrzesiński T. Analiza transkryptomu guzów raka jasnokomórkowego nerki, ze szczególnym uwzględnieniem ekspresji genów kodujących białka transbłonowe . [Doctoral Dissertation]. Uniwersytet im. Adama Mickiewicza w Poznaniu; 2016. Available from: http://hdl.handle.net/10593/14268


Universitat de Valencia

19. Valencia Villa, Gerardo J. Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas .

Degree: 2013, Universitat de Valencia

 La angiogénesis en el carcinoma de células renales claras (ccRCC) es un proceso influenciado por sustancias producidas en su mayoría por el tumor en respuesta… (more)

Subjects/Keywords: radiation exposure to persistent low-dose (CPLDIR); immunohistochemistry; angiogenesis; angiogenic factors; clear cell renal cell carcinoma (ccRCC); microvascular density (MVD); morphometry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Valencia Villa, G. J. (2013). Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas . (Doctoral Dissertation). Universitat de Valencia. Retrieved from http://hdl.handle.net/10550/26318

Chicago Manual of Style (16th Edition):

Valencia Villa, Gerardo J. “Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas .” 2013. Doctoral Dissertation, Universitat de Valencia. Accessed April 14, 2021. http://hdl.handle.net/10550/26318.

MLA Handbook (7th Edition):

Valencia Villa, Gerardo J. “Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas .” 2013. Web. 14 Apr 2021.

Vancouver:

Valencia Villa GJ. Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas . [Internet] [Doctoral dissertation]. Universitat de Valencia; 2013. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10550/26318.

Council of Science Editors:

Valencia Villa GJ. Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativo de tumores procedentes de tres regiones geográficas . [Doctoral Dissertation]. Universitat de Valencia; 2013. Available from: http://hdl.handle.net/10550/26318


Freie Universität Berlin

20. Ralla, Bernhard. Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom.

Degree: 2020, Freie Universität Berlin

 Das Nierenzellkarzinom (NZK) stellt weltweit die dritthäufigste bösartige Erkrankung in der Urologie dar. Es werden das lokal begrenzte, das lokal fortgeschrittene und das metastasierte Krankheitsstadium… (more)

Subjects/Keywords: Renal cell carcinoma; Metastastic renal cell carcinoma; Prognosis renal cell carcinoma; ddc:610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ralla, B. (2020). Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-27293

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ralla, Bernhard. “Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom.” 2020. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-27293.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ralla, Bernhard. “Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom.” 2020. Web. 14 Apr 2021.

Vancouver:

Ralla B. Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom. [Internet] [Thesis]. Freie Universität Berlin; 2020. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-27293.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ralla B. Prognosefaktoren und Therapiestrategien bei Patienten mit lokal fortgeschrittenem oder metastasiertem Nierenzellkarzinom. [Thesis]. Freie Universität Berlin; 2020. Available from: http://dx.doi.org/10.17169/refubium-27293

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Gaudelot, Kelly. Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell.

Degree: Docteur es, Sciences de la vie et de la santé, 2017, Université Lille II – Droit et Santé

Le carcinome rénal à cellules claires (cRCC) est le principal type histologique de carcinome rénal et l'une des tumeurs les plus résistantes à la chimio… (more)

Subjects/Keywords: Tumeurs du rein; MicroARN; Chimiorésistance; Récepteur PPAR alpha; MiR-21; MicroRNA; Eceptor PPARα; MiR-21; Renal clear cell carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gaudelot, K. (2017). Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell. (Doctoral Dissertation). Université Lille II – Droit et Santé. Retrieved from http://www.theses.fr/2017LIL2S011

Chicago Manual of Style (16th Edition):

Gaudelot, Kelly. “Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell.” 2017. Doctoral Dissertation, Université Lille II – Droit et Santé. Accessed April 14, 2021. http://www.theses.fr/2017LIL2S011.

MLA Handbook (7th Edition):

Gaudelot, Kelly. “Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell.” 2017. Web. 14 Apr 2021.

Vancouver:

Gaudelot K. Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell. [Internet] [Doctoral dissertation]. Université Lille II – Droit et Santé 2017. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2017LIL2S011.

Council of Science Editors:

Gaudelot K. Rôle de miR-21 dans la progression tumorale et la chimiorésistance des carcinomes rénaux à cellules claires : étude de la boucle de régulation entre miR-21 et PPARα : Role of microRNA-21 on tumor progression and chemoresistance of renal clear cell. [Doctoral Dissertation]. Université Lille II – Droit et Santé 2017. Available from: http://www.theses.fr/2017LIL2S011


University of Toronto

22. Lobo, Nazleen. Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements.

Degree: 2013, University of Toronto

While extirpative surgery is curative for localized clear cell renal cell carcinoma (ccRCC), many patients develop recurrences or present with metastatic disease. Several aspects of… (more)

Subjects/Keywords: Renal Cell Carcinoma; Cell Lines; 0760

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lobo, N. (2013). Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/43099

Chicago Manual of Style (16th Edition):

Lobo, Nazleen. “Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements.” 2013. Masters Thesis, University of Toronto. Accessed April 14, 2021. http://hdl.handle.net/1807/43099.

MLA Handbook (7th Edition):

Lobo, Nazleen. “Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements.” 2013. Web. 14 Apr 2021.

Vancouver:

Lobo N. Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements. [Internet] [Masters thesis]. University of Toronto; 2013. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1807/43099.

Council of Science Editors:

Lobo N. Derivation and Genetic Validation of Clear Cell Renal Cell Carcinoma Cell Lines and Characterization of Their Growth Requirements. [Masters Thesis]. University of Toronto; 2013. Available from: http://hdl.handle.net/1807/43099

23. Cláudia Tarcila Gomes Sares. Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras.

Degree: 2018, University of São Paulo

O carcinoma renal de células claras é o tumor renal maligno mais frequentemente diagnosticado nos adultos. Uma série de defeitos genéticos tem sido observada no… (more)

Subjects/Keywords: Carcinoma renal de células claras; DNA mitocondrial; Pseudogenes nucleares de origem mitocondrial (NUMTs); Sequenciamento genético; Clear cell renal carcinoma; Genetic sequencing; Mitochondrial DNA; Nuclear mitochondrial pseudogenes (NUMTs)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sares, C. T. G. (2018). Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/17/17137/tde-24072018-151829/

Chicago Manual of Style (16th Edition):

Sares, Cláudia Tarcila Gomes. “Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras.” 2018. Doctoral Dissertation, University of São Paulo. Accessed April 14, 2021. http://www.teses.usp.br/teses/disponiveis/17/17137/tde-24072018-151829/.

MLA Handbook (7th Edition):

Sares, Cláudia Tarcila Gomes. “Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras.” 2018. Web. 14 Apr 2021.

Vancouver:

Sares CTG. Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras. [Internet] [Doctoral dissertation]. University of São Paulo; 2018. [cited 2021 Apr 14]. Available from: http://www.teses.usp.br/teses/disponiveis/17/17137/tde-24072018-151829/.

Council of Science Editors:

Sares CTG. Avaliação da contaminação do sequenciamento do genoma mitocondrial por inserções nucleares de origem mitocondrial (NUMTs) no carcinoma renal de células claras. [Doctoral Dissertation]. University of São Paulo; 2018. Available from: http://www.teses.usp.br/teses/disponiveis/17/17137/tde-24072018-151829/

24. Dugay, Frédéric. PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis.

Degree: Docteur es, Biologie et sciences de la santé, 2014, Rennes 1

 Les carcinomes rénaux représentent environ 3% des cancers chez l’adulte. Les plus fréquents parmi ces tumeurs sont les carcinomes rénaux à cellules claires (CRCC) (70%… (more)

Subjects/Keywords: Carcinomes rénaux à cellules claires; Cytogénétique; Polarité cellulaire; Par-3; Agressivité clinique; Clear cell renal cell carcinoma, cytogenetic; Cell polarity; Par-3; Clinical aggressiveness

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dugay, F. (2014). PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis. (Doctoral Dissertation). Rennes 1. Retrieved from http://www.theses.fr/2014REN1B014

Chicago Manual of Style (16th Edition):

Dugay, Frédéric. “PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis.” 2014. Doctoral Dissertation, Rennes 1. Accessed April 14, 2021. http://www.theses.fr/2014REN1B014.

MLA Handbook (7th Edition):

Dugay, Frédéric. “PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis.” 2014. Web. 14 Apr 2021.

Vancouver:

Dugay F. PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis. [Internet] [Doctoral dissertation]. Rennes 1; 2014. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2014REN1B014.

Council of Science Editors:

Dugay F. PAR-3 et  carcinome rénal à cellules claires : rôle dans la tumorigénèse : PAR-3 and clear cell renal cell carcinoma : role in tumorigenesis. [Doctoral Dissertation]. Rennes 1; 2014. Available from: http://www.theses.fr/2014REN1B014


Freie Universität Berlin

25. Lu, Hongbiao. Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten.

Degree: 2016, Freie Universität Berlin

 Hintergrund: Die Informationen von zellfreier, zirkulierender DNA (cfDNA) als potenzieller diagnostischer und/oder prognostischer Marker bei Patienten mit einem Nierenzellkarzinom sind widersprüchlich. Dies ist offensichtlich bedingt… (more)

Subjects/Keywords: clear cell renal cell carcinoma; circulating cell-free DNA; diagnostic, prognostic markers; metastasis; predictive models; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lu, H. (2016). Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-10633

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lu, Hongbiao. “Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten.” 2016. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-10633.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lu, Hongbiao. “Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten.” 2016. Web. 14 Apr 2021.

Vancouver:

Lu H. Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten. [Internet] [Thesis]. Freie Universität Berlin; 2016. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-10633.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lu H. Diagnostisches und prognostisches Potential von zirkulierenden zellfreien genomischen und Mitochondrien-DNA-Fragmenten bei klarzelligen Nierenzellkarzinompatienten. [Thesis]. Freie Universität Berlin; 2016. Available from: http://dx.doi.org/10.17169/refubium-10633

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Ambrosetti, Damien. Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms.

Degree: Docteur es, Interactions moléculaires et cellulaires, 2015, Nice

Les carcinomes rénaux (RCC) sont subdivisés en plusieurs sous-types, définis selon des critères histologiques, phénotypiques et génétiques. Le diagnostic différentiel de ces tumeurs est primordial… (more)

Subjects/Keywords: Carcinomes rénaux; RCC à cellules claires; RCC papillaires; MCT1; GLUT1; CAXII; HIF1; HIF2; HAF; Renal cell carcinoma; Clear cell RCC; Papillary RCC; MCT1; GLUT1; CAXII; HIF1; HIF2; HAF

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ambrosetti, D. (2015). Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms. (Doctoral Dissertation). Nice. Retrieved from http://www.theses.fr/2015NICE4143

Chicago Manual of Style (16th Edition):

Ambrosetti, Damien. “Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms.” 2015. Doctoral Dissertation, Nice. Accessed April 14, 2021. http://www.theses.fr/2015NICE4143.

MLA Handbook (7th Edition):

Ambrosetti, Damien. “Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms.” 2015. Web. 14 Apr 2021.

Vancouver:

Ambrosetti D. Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms. [Internet] [Doctoral dissertation]. Nice; 2015. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2015NICE4143.

Council of Science Editors:

Ambrosetti D. Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques : Renal cell carcinoma : molecular characterization and metabolic pathways dependent on hypoxic mechanisms. [Doctoral Dissertation]. Nice; 2015. Available from: http://www.theses.fr/2015NICE4143

27. Hascoët, Pauline. Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis.

Degree: Docteur es, Biologie, 2016, Rennes 1

Le syndrome von Hippel Lindau (VHL) prédispose au développement de multiples tumeurs hautement vascularisées, telles que des hémangioblastomes rétiniens ou du système nerveux central, des… (more)

Subjects/Keywords: Cancer du rein à cellules claires; Maladie de von Hippel Lindau; Suppresseur de tumeur; Metalloprotéases; TGF-Β; Clear cell renal cell carcinoma; VHL disease; Tumor suppressor; Metalloproteases; TGF-Β

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hascoët, P. (2016). Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis. (Doctoral Dissertation). Rennes 1. Retrieved from http://www.theses.fr/2016REN1B005

Chicago Manual of Style (16th Edition):

Hascoët, Pauline. “Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis.” 2016. Doctoral Dissertation, Rennes 1. Accessed April 14, 2021. http://www.theses.fr/2016REN1B005.

MLA Handbook (7th Edition):

Hascoët, Pauline. “Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis.” 2016. Web. 14 Apr 2021.

Vancouver:

Hascoët P. Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis. [Internet] [Doctoral dissertation]. Rennes 1; 2016. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2016REN1B005.

Council of Science Editors:

Hascoët P. Étude de pVHL₁₇₂, une isoforme du suppresseur de tumeur von Hippel Lindau : implication dans la tumorigenèse rénale : Study of pVHL₁₇₂, an isoform of the tumor suppressor von Hippel Lindau : involvement in kidney tumorigenesis. [Doctoral Dissertation]. Rennes 1; 2016. Available from: http://www.theses.fr/2016REN1B005

28. Kammerer-Jacquet, Solène-Florence. Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy.

Degree: Docteur es, Biologie et sciences de la santé, 2016, Rennes 1

 Le carcinome rénal à cellules claires (ccRCC) est la tumeur du rein la plus fréquente. Il se caractérise par une inactivation fréquente du gène suppresseur… (more)

Subjects/Keywords: Carcinomes à cellules claires du rein; Métastases synchrones; Métastases métachrones; Sunitinib; Cabozantinib; Nivolumab; Réponse; Résistance; Clear cell renal cell carcinoma; Synchronous metastasis; Metachronous metastasis; Sunitinib; Cabozantinib; Nivolumab; Response; Resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kammerer-Jacquet, S. (2016). Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy. (Doctoral Dissertation). Rennes 1. Retrieved from http://www.theses.fr/2016REN1B038

Chicago Manual of Style (16th Edition):

Kammerer-Jacquet, Solène-Florence. “Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy.” 2016. Doctoral Dissertation, Rennes 1. Accessed April 14, 2021. http://www.theses.fr/2016REN1B038.

MLA Handbook (7th Edition):

Kammerer-Jacquet, Solène-Florence. “Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy.” 2016. Web. 14 Apr 2021.

Vancouver:

Kammerer-Jacquet S. Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy. [Internet] [Doctoral dissertation]. Rennes 1; 2016. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2016REN1B038.

Council of Science Editors:

Kammerer-Jacquet S. Carcinome à cellules claires du rein : phénotype métastatique et résistance aux thérapies ciblées : Clear cell renal cell carcinoma : metastatic phenotype and resistance to anti-angiogenic therapy. [Doctoral Dissertation]. Rennes 1; 2016. Available from: http://www.theses.fr/2016REN1B038


Freie Universität Berlin

29. Wotschofsky, Zofia. Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma.

Degree: 2014, Freie Universität Berlin

 Background/Objective: MicroRNAs (miRNAs) are non-protein coding RNAs of approximately 22 nucleotides and are involved in the regulation of about 30% of all genes. They play… (more)

Subjects/Keywords: clear cell renal cell carcinoma; microRNAs; reference genes; RT-qPCR; Metastasis; recurrence risk prediction; prognostic markers; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wotschofsky, Z. (2014). Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-13113

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wotschofsky, Zofia. “Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma.” 2014. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-13113.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wotschofsky, Zofia. “Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma.” 2014. Web. 14 Apr 2021.

Vancouver:

Wotschofsky Z. Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma. [Internet] [Thesis]. Freie Universität Berlin; 2014. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-13113.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wotschofsky Z. Deregulated microRNAs and their diagnostic and prognostic impact in clear cell renal cell carcinoma. [Thesis]. Freie Universität Berlin; 2014. Available from: http://dx.doi.org/10.17169/refubium-13113

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. Hamaidi, Imene. Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2017, Université de Strasbourg

Le carcinome à cellules rénales claires métastatique (CCC) demeure résistant aux thérapies actuelles. Les travaux précédents ont montré des similitudes mécanistiques entre tumorigenèse et néphrogenèse.… (more)

Subjects/Keywords: Carcinome à cellules rénales claires (CCC); Lim1; Métastases; PDA-Nf; SiRNAs; Nouvelle thérapie; Clear cell renal cell carcinoma (CCC); Lim1; Metastases; PDA-Nf; SiRNA; New therapy; 572.8; 616.99

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hamaidi, I. (2017). Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer. (Doctoral Dissertation). Université de Strasbourg. Retrieved from http://www.theses.fr/2017STRAJ069

Chicago Manual of Style (16th Edition):

Hamaidi, Imene. “Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer.” 2017. Doctoral Dissertation, Université de Strasbourg. Accessed April 14, 2021. http://www.theses.fr/2017STRAJ069.

MLA Handbook (7th Edition):

Hamaidi, Imene. “Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer.” 2017. Web. 14 Apr 2021.

Vancouver:

Hamaidi I. Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer. [Internet] [Doctoral dissertation]. Université de Strasbourg; 2017. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2017STRAJ069.

Council of Science Editors:

Hamaidi I. Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé : Involvement of the developmental factor Lim1, a new oncogene, in advanced human kidney cancer. [Doctoral Dissertation]. Université de Strasbourg; 2017. Available from: http://www.theses.fr/2017STRAJ069

[1] [2] [3] [4] [5] … [1319]

.